181 related articles for article (PubMed ID: 26412593)
21. Erythropoietin receptor expression and correlation to tamoxifen response and prognosis in breast cancer.
Larsson AM; Jirström K; Fredlund E; Nilsson S; Rydén L; Landberg G; Påhlman S
Clin Cancer Res; 2009 Sep; 15(17):5552-9. PubMed ID: 19706814
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietin and erythropoietin receptor expression in human cancer.
Acs G; Acs P; Beckwith SM; Pitts RL; Clements E; Wong K; Verma A
Cancer Res; 2001 May; 61(9):3561-5. PubMed ID: 11325818
[TBL] [Abstract][Full Text] [Related]
23. Erythropoietin promotes hair shaft growth in cultured human hair follicles and modulates hair growth in mice.
Kang BM; Shin SH; Kwack MH; Shin H; Oh JW; Kim J; Moon C; Moon C; Kim JC; Kim MK; Sung YK
J Dermatol Sci; 2010 Aug; 59(2):86-90. PubMed ID: 20554434
[TBL] [Abstract][Full Text] [Related]
24. Expression of erythropoietin and erythropoietin receptor in cervical cancer and relationship to survival, hypoxia, and apoptosis.
Leo C; Horn LC; Rauscher C; Hentschel B; Liebmann A; Hildebrandt G; Höckel M
Clin Cancer Res; 2006 Dec; 12(23):6894-900. PubMed ID: 17145806
[TBL] [Abstract][Full Text] [Related]
25. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
[TBL] [Abstract][Full Text] [Related]
26. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
Arcasoy MO; Karayal AF
Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
[TBL] [Abstract][Full Text] [Related]
27. Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture.
Nagai A; Nakagawa E; Choi HB; Hatori K; Kobayashi S; Kim SU
J Neuropathol Exp Neurol; 2001 Apr; 60(4):386-92. PubMed ID: 11305874
[TBL] [Abstract][Full Text] [Related]
28. The role of erythropoietin and erythropoietin receptor in malignant laryngeal tumors.
Vukelic J; Dobrila-Dintinjana R; Jonjic N; Dekanic A; Ilijic V
Med Hypotheses; 2013 Dec; 81(6):1155-8. PubMed ID: 24134826
[TBL] [Abstract][Full Text] [Related]
29. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
[TBL] [Abstract][Full Text] [Related]
30. Post-secretion neutralization of transgene-derived effect: soluble erythropoietin receptor/IgG1Fc expressed in liver neutralizes erythropoietin produced in muscle.
Maruyama H; Higuchi M; Higuchi N; Kameda S; Saito M; Sugawa M; Matsuzaki J; Neichi T; Yokoyama S; Miyazaki Y; Miyazaki J; Gejyo F
J Gene Med; 2004 Feb; 6(2):228-37. PubMed ID: 14978776
[TBL] [Abstract][Full Text] [Related]
31. PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma.
Hanna JA; Garcia MR; Go JC; Finkelstein D; Kodali K; Pagala V; Wang X; Peng J; Hatley ME
Cell Death Dis; 2016 Jun; 7(6):e2256. PubMed ID: 27277678
[TBL] [Abstract][Full Text] [Related]
32. Lack of expression and function of erythropoietin receptors in the kidney.
Elliott S; Busse L; Swift S; McCaffery I; Rossi J; Kassner P; Begley CG
Nephrol Dial Transplant; 2012 Jul; 27(7):2733-45. PubMed ID: 22167585
[TBL] [Abstract][Full Text] [Related]
33. Lineage-restricted recruitment of immature hematopoietic progenitor cells in response to Epo after normal hematopoietic cell transfection with EpoR.
McArthur GA; Longmore GD; Klingler K; Johnson GR
Exp Hematol; 1995 Jul; 23(7):645-54. PubMed ID: 7601257
[TBL] [Abstract][Full Text] [Related]
34. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma.
Acs G; Zhang PJ; Rebbeck TR; Acs P; Verma A
Cancer; 2002 Sep; 95(5):969-81. PubMed ID: 12209679
[TBL] [Abstract][Full Text] [Related]
36. Location and the functionality of erythropoietin receptor(s) in A2780 cells.
Solár P; Hrčková G; Varinská L; Solárová Z; Kriška J; Uhrínová I; Kello M; Mojžiš J; Fedoročko P; Sytkowski AJ
Oncol Rep; 2012 Jul; 28(1):141-6. PubMed ID: 22552716
[TBL] [Abstract][Full Text] [Related]
37. FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target.
Kuda M; Kohashi K; Yamada Y; Maekawa A; Kinoshita Y; Nakatsura T; Iwamoto Y; Taguchi T; Oda Y
Tumour Biol; 2016 Apr; 37(4):5213-23. PubMed ID: 26553361
[TBL] [Abstract][Full Text] [Related]
38. Glioblastoma multiforme cells: expression of erythropoietin receptor and response to erythropoietin.
Yin D; Kawabata H; Tcherniamtchouk O; Huynh T; Black KL; Koeffler HP
Int J Oncol; 2007 Nov; 31(5):1193-8. PubMed ID: 17912447
[TBL] [Abstract][Full Text] [Related]
39. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
[TBL] [Abstract][Full Text] [Related]
40. Induction of signalling in non-erythroid cells by pharmacological levels of erythropoietin.
Dunlop EA; Percy MJ; Boland MP; Maxwell AP; Lappin TR
Neurodegener Dis; 2006; 3(1-2):94-100. PubMed ID: 16909043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
